Condition
Neurotrophic Corneal Ulcer
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Terminated1
Unknown1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04573647Recruiting
OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate
NCT05940376Unknown
Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy
NCT05809245Not ApplicableTerminatedPrimary
Corneal Neurotization as a Treatment for Neurotrophic Keratopathy
Showing all 3 trials